Oncolytic Virus Immunotherapy Market : Global Industry Analysis and Forecast to 2022 to 2031

1
Oncolytic Virus Immunotherapy Market
Global Industry Analysis and Forecast to 2022 to
2031
Report Id PMRREP15262 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
Oncolytic Virus Immunotherapy Market
Global Industry Analysis and Forecast to 2022 to
2031

• Widely adopted, traditional chemotherapy has
  remained the cornerstone for first-line treatment
  for advanced cancers traditionally. There is an
  abundant interest in the idea of dodging such
  modestly effective but potentially toxic approach
  with vaccine targeted cancer therapies or virus
  immunotherapies that hold significant promise of
  superior efficacy and improved quality of life.
• While forerunners such as Bristol-Myers Squibb,
  Merck, and Roche have the most developed
  portfolios of immunotherapy drugs, AstraZeneca
  and Glaxo are known for excellent portfolios of
  early checkpoint-based immunotherapy approaches.
  The revenue expectation for most of these drugs
  is approximately US 1 Bn.
• Amgen has an existing product portfolio of
  oncolytic virus, and combination trials with
  other cancer therapies are in the pipeline.
  Certain estimates dictate the overall
  immunotherapy market to gain as much as a 50
  share of the overall cancer treatment market
  within the next decade. It is an expectation that
  is coming into reality with every regulatory
  approval obtained by the key players in this
  field.
• A new study by Persistence Market Research
  predicts that the global oncolytic virus
  immunotherapy market will be valued at US 214
  Mn by 2029-end, expanding at a promising CAGR of
  12 during the forecast period of 2019-2029.
• .
• .

 Get Sample Copy of Report _at_  https//www.persiste
ncemarketresearch.com/samples/15262
4
Market Segmentation
Access Full Report _at_ https//www.persistencemarket
research.com/market-research/oncolytic-virus-immun
otherapy-market.asp
5
(No Transcript)